GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sinocare Inc (SZSE:300298) » Definitions » Research & Development

Sinocare (SZSE:300298) Research & Development : ¥376 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Sinocare Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Sinocare's Research & Development for the three months ended in Mar. 2024 was ¥96 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ¥376 Mil.


Sinocare Research & Development Historical Data

The historical data trend for Sinocare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocare Research & Development Chart

Sinocare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 161.34 182.49 182.43 306.31 356.41

Sinocare Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 75.72 85.54 84.16 110.98 95.59

Sinocare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥376 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinocare  (SZSE:300298) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Sinocare Research & Development Related Terms

Thank you for viewing the detailed overview of Sinocare's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinocare (SZSE:300298) Business Description

Traded in Other Exchanges
N/A
Address
No.265 Guyuan Road, Hi-tech Zone, Hunan Province, Changsha, CHN, 410205
Sinocare Inc operates in the healthcare industry. It is engaged in the development, manufacturing, and marketing of diagnosis testing products for people with chronic diseases and healthcare professionals. Its product range covers household blood glucose meter, medical blood glucose meter, urinary microalbumin test strip and blood lipid uric acid products. In addition, the company also provides diabetes management information systems.
Executives
Li Shao Bo Directors, executives
Che Hong Jing Director
Wang Shi Min Executives
Huang An Guo Directors, executives
Directors, executives
Pan Shu Guang Securities Affairs Representative
Zhou Qing Hua Supervisors
Ning Gui Chun Supervisors
Wang Rui Securities Affairs Representative
Chen Ji Dong Supervisors
Che Hong Li Directors, executives
Zhang Fan Director

Sinocare (SZSE:300298) Headlines

No Headlines